Back
profile

Tim Lugo

Research Analyst

About Mr. Lugo

Tim Lugo, partner, joined William Blair in 2005 and focuses on the therapeutics space. Before joining William Blair, he worked at Pacific Growth Equities as a junior analyst on a number of specialty pharmaceutical companies. Mr. Lugo was named No. 1 stock picker and No. 3 earnings estimator in the 2016 Thomson Reuters Analyst Awards for his coverage of biotechnology. Mr. Lugo has a B.A. in molecular and cellular biology (with an emphasis in genetics) and a B.A. in economics, both from the University of California, Berkeley.

Healthcare

Specialty: Therapeutics

News and Press

Atea Pharmaceuticals, Inc.: Initiation of Research Coverage 9 Meters Biopharma, Inc.: Initiation of Research Coverage Lyra Therapeutics, Inc.: Initiation of Research Coverage

Coverage List
TICKER COMPANY
NMTR 9 Meters Biopharma, Inc.
ACER Acer Therapeutics Inc.
ACRS Aclaris Therapeutics, Inc.
ADMS Adamas Pharmaceuticals, Inc.
AGRX Agile Therapeutics, Inc.
ALBO Albireo Pharma, Inc.
ALLK Allakos Inc.
AVIR Atea Pharmaceuticals, Inc.
BDSI BioDelivery Sciences International, Inc.
BHVN Biohaven Pharmaceutical Holding Co. Ltd
BMRN BioMarin Pharmaceutical Inc.
COLL Collegium Pharmaceutical, Inc.
EGRX Eagle Pharmaceuticals, Inc.
LYRA Lyra Therapeutics, Inc.
OVID Ovid Therapeutics Inc.
RVNC Revance Therapeutics, Inc.
SAGE Sage Therapeutics, Inc.
SRPT Sarepta Therapeutics, Inc.
TVTX Travere Therapeutics, Inc.
VTGN VistaGen Therapeutics, Inc.
XENE Xenon Pharmaceuticals Inc.
ZGNX Zogenix, Inc.